ARCHITECT CYCLOSPORINE 01L75-25

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05,foreign,health professi report with the FDA on 2015-06-30 for ARCHITECT CYCLOSPORINE 01L75-25 manufactured by Abbott Laboratories.

Event Text Entries

[20037271] The customer states that one patient sample generated architect cyclosporine assay results of 231. 8 and 130. 7 ug/l. Controls were not run on this day because the customer did not have any at hand, but they were within specifications on the day the assay was calibrated. The result of 231. 8 ug/l was reported from the lab as a consequence of the configuration of the customer's laboratory interface and questioned by the patient's physician as not fitting the patient's clinical condition. The sample was sent to two different labs for testing (methods unknown) and results of 190. 2 and 58. 0 ug/l were returned. The customer then retested the sample at their facility and generated a result of 132. 3 ug/l. Previously, this patient had generated results of 99, 100 and 110 ug/l. There has been no impact to patient care reported.
Patient Sequence No: 1, Text Type: D, B5


[20287454] An evaluation is in process. A follow-up report will be submitted when the evaluation is complete. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[26768031] No returns were made available from the customer site for this evaluation. A review of complaint tracking and trending metrics was performed and identified no adverse trends in conjunction with the complaint issue currently under evaluation. Accuracy testing was performed using in-house retained reagents of lot 43438m500. Replicates of a patient sample matrix based panel were tested on one architect i-system. All results fell within specifications, indicating acceptable performance of this assay lot. The architect cyclosporine assay package insert contains information to address the current customer issue. Based on the available information from the customer site and from the results of this evaluation, there is no evidence to reasonably suggest a product malfunction occurred. The issue involved one discreet patient sample and multiple retests of the sample produced inconsistent results indicating a possible sample integrity issue. Additionally, the customer did not run controls for the assay on the day the patient sample was tested.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1415939-2015-00020
MDR Report Key4879867
Report Source01,05,FOREIGN,HEALTH PROFESSI
Date Received2015-06-30
Date of Report2015-06-10
Date Mfgr Received2015-08-06
Device Manufacturer Date2014-11-01
Date Added to Maude2015-07-16
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNOEMI ROMERO-KONDOS, RN BSN
Manufacturer Street100 ABBOTT PARK ROAD DEPT. 09B9, LCCP1-3
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone224667-512
Manufacturer G1ABBOTT LABORATORIES
Manufacturer Street100 ABBOTT PARK ROAD
Manufacturer CityABBOTT PARK IL 600643500
Manufacturer CountryUS
Manufacturer Postal Code600643500
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameARCHITECT CYCLOSPORINE
Generic NameCYCLOSPORINE
Product CodeMKW
Date Received2015-06-30
Catalog Number01L75-25
Lot Number43438M500
Device Expiration Date2015-09-30
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerABBOTT LABORATORIES
Manufacturer Address100 ABBOTT PARK ROAD ABBOTT PARK IL 600643500 US 600643500


Patients

Patient NumberTreatmentOutcomeDate
10 2015-06-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.